VTE Recurrence Risk Factors and poor-response AML Transplant Outcome Indicators
Authors Dr. David-Alexandre Trégouët and Dr. Johannes Schetelig discuss their research on VTE recurrence risk factors and outcomes for poor-response AML transplant patients. Their studies, published in Blood journal, explore genomic evidence for VTE recurrence and compare…